Verastem, Inc. logo

Verastem, Inc.

NASDAQ:VSTM

Overview | Financials
Company Name Verastem, Inc.
Symbol VSTM
Currency USD
Price 2.81
Market Cap 113,084,797
Dividend Yield 0%
52-week-range 2.1 - 14.22
Industry Biotechnology
Sector Healthcare
CEO Mr. Daniel W. Paterson
Website https://www.verastem.com

An error occurred while fetching data.

About Verastem, Inc.

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages

Related Stocks

Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc.

VYGR

6.25 USD

Theratechnologies Inc. logo

Theratechnologies Inc.

THTX

1.35 USD

Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

OCUL

9 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

12.59 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

16.25 USD

Financials

Numbers are in millions USD

Numbers are in millions USD